Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.

Ferroportin (FPN) mediates iron export from cells; FPN mutations are associated with the iron overloading disorder hemochromatosis. Previously, we found that the A77D, V162del, and G490D mutations inhibited FPN activity, but that other disease-associated FPN variants retained full iron export capabi...

Full description

Bibliographic Details
Main Authors: Drakesmith, H, Schimanski, L, Ormerod, E, Merryweather-Clarke, A, Viprakasit, V, Edwards, J, Sweetland, E, Bastin, J, Cowley, D, Chinthammitr, Y, Robson, K, Townsend, A
Format: Journal article
Language:English
Published: 2005
_version_ 1797098365886922752
author Drakesmith, H
Schimanski, L
Ormerod, E
Merryweather-Clarke, A
Viprakasit, V
Edwards, J
Sweetland, E
Bastin, J
Cowley, D
Chinthammitr, Y
Robson, K
Townsend, A
author_facet Drakesmith, H
Schimanski, L
Ormerod, E
Merryweather-Clarke, A
Viprakasit, V
Edwards, J
Sweetland, E
Bastin, J
Cowley, D
Chinthammitr, Y
Robson, K
Townsend, A
author_sort Drakesmith, H
collection OXFORD
description Ferroportin (FPN) mediates iron export from cells; FPN mutations are associated with the iron overloading disorder hemochromatosis. Previously, we found that the A77D, V162del, and G490D mutations inhibited FPN activity, but that other disease-associated FPN variants retained full iron export capability. The peptide hormone hepcidin inhibits FPN as part of a homeostatic negative feedback loop. We measured surface expression and function of wild-type FPN and fully active FPN mutants in the presence of hepcidin. We found that the Y64N and C326Y mutants of FPN are completely resistant to hepcidin inhibition and that N144D and N144H are partially resistant. Hemochromatosis-associated FPN mutations, therefore, either reduce iron export ability or produce an FPN variant that is insensitive to hepcidin. The former mutation type is associated with Kupffer-cell iron deposition and normal transferrin saturation in vivo, whereas patients with the latter category of FPN mutation have high transferrin saturation and tend to deposit iron throughout the liver parenchyma. FPN-linked hemochromatosis may have a variable pathogenesis depending on the causative FPN mutant.
first_indexed 2024-03-07T05:08:29Z
format Journal article
id oxford-uuid:dabd774a-869e-48f3-9cd9-501c2578ab7c
institution University of Oxford
language English
last_indexed 2024-03-07T05:08:29Z
publishDate 2005
record_format dspace
spelling oxford-uuid:dabd774a-869e-48f3-9cd9-501c2578ab7c2022-03-27T09:05:25ZResistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dabd774a-869e-48f3-9cd9-501c2578ab7cEnglishSymplectic Elements at Oxford2005Drakesmith, HSchimanski, LOrmerod, EMerryweather-Clarke, AViprakasit, VEdwards, JSweetland, EBastin, JCowley, DChinthammitr, YRobson, KTownsend, AFerroportin (FPN) mediates iron export from cells; FPN mutations are associated with the iron overloading disorder hemochromatosis. Previously, we found that the A77D, V162del, and G490D mutations inhibited FPN activity, but that other disease-associated FPN variants retained full iron export capability. The peptide hormone hepcidin inhibits FPN as part of a homeostatic negative feedback loop. We measured surface expression and function of wild-type FPN and fully active FPN mutants in the presence of hepcidin. We found that the Y64N and C326Y mutants of FPN are completely resistant to hepcidin inhibition and that N144D and N144H are partially resistant. Hemochromatosis-associated FPN mutations, therefore, either reduce iron export ability or produce an FPN variant that is insensitive to hepcidin. The former mutation type is associated with Kupffer-cell iron deposition and normal transferrin saturation in vivo, whereas patients with the latter category of FPN mutation have high transferrin saturation and tend to deposit iron throughout the liver parenchyma. FPN-linked hemochromatosis may have a variable pathogenesis depending on the causative FPN mutant.
spellingShingle Drakesmith, H
Schimanski, L
Ormerod, E
Merryweather-Clarke, A
Viprakasit, V
Edwards, J
Sweetland, E
Bastin, J
Cowley, D
Chinthammitr, Y
Robson, K
Townsend, A
Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
title Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
title_full Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
title_fullStr Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
title_full_unstemmed Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
title_short Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
title_sort resistance to hepcidin is conferred by hemochromatosis associated mutations of ferroportin
work_keys_str_mv AT drakesmithh resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT schimanskil resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT ormerode resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT merryweatherclarkea resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT viprakasitv resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT edwardsj resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT sweetlande resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT bastinj resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT cowleyd resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT chinthammitry resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT robsonk resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin
AT townsenda resistancetohepcidinisconferredbyhemochromatosisassociatedmutationsofferroportin